Lexington, MA, United States of America

Arunthathi Thiagalingam


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arunthathi Thiagalingam: Innovator in Genetic Research

Introduction

Arunthathi Thiagalingam is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of genetic research, particularly in the area of cancer diagnostics and therapeutics. With a total of 2 patents, her work has the potential to impact the medical community profoundly.

Latest Patents

Thiagalingam's latest patents include a method for detecting a differentially expressed sequence. This invention relates to novel human genes, proteins expressed by these genes, and variants of the proteins. It also encompasses diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue. Another significant patent is focused on human genes and gene expression products, which shares similar themes of novel human genes and their applications in diagnostics and therapeutics.

Career Highlights

Throughout her career, Arunthathi has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Bayer Healthcare LLC. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Jon H Astle and Christopher C Burgess. Their collaborative efforts have further advanced the research and development of innovative solutions in genetic diagnostics.

Conclusion

Arunthathi Thiagalingam's contributions to genetic research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in cancer diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…